NCT03172624 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 32
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 64
- units
- Participants
- groups
- description
- Enrolled patients will be treated with nivolumab 3 mg/kg every 2 weeks plus ipilimumab 1 mg/kg every 6 weeks (1 cycle= 6 weeks). Nivolumab: nivolumab 3 mg/kg every 2 weeks Ipilimumab: ipilimumab 1 mg/kg every 6 weeks (1 cycle= 6 weeks)
- id
- BG000
- title
- R/M Adenoid Cystic Carcinoma (ACC)
- description
- Enrolled patients will be treated with nivolumab 3 mg/kg every 2 weeks plus ipilimumab 1 mg/kg every 6 weeks (1 cycle= 6 weeks). Nivolumab: nivolumab 3 mg/kg every 2 weeks Ipilimumab: ipilimumab 1 mg/kg every 6 weeks (1 cycle= 6 weeks)
- id
- BG001
- title
- R/M SGC of Any Histology, Except ACC (Non ACC)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 30
- upper Limit
- 88
- value
- 58
- group Id
- BG001
- lower Limit
- 57
- upper Limit
- 88
- value
- 64
- group Id
- BG002
- lower Limit
- 30
- upper Limit
- 88
- value
- 64
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 31
- title
- Female
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 33
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 30
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 59
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 4
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 54
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 5
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 32
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 64
- title
- United States
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 32
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 64
- units
- Participants
- groups
- description
- Enrolled patients will be treated with nivolumab 3 mg/kg every 2 weeks plus ipilimumab 1 mg/kg every 6 weeks (1 cycle= 6 weeks). Nivolumab: nivolumab 3 mg/kg every 2 weeks Ipilimumab: ipilimumab 1 mg/kg every 6 weeks (1 cycle= 6 weeks)
- id
- BG000
- title
- R/M Adenoid Cystic Carcinoma (ACC)
- description
- Enrolled patients will be treated with nivolumab 3 mg/kg every 2 weeks plus ipilimumab 1 mg/kg every 6 weeks (1 cycle= 6 weeks). Nivolumab: nivolumab 3 mg/kg every 2 weeks Ipilimumab: ipilimumab 1 mg/kg every 6 weeks (1 cycle= 6 weeks)
- id
- BG001
- title
- R/M SGC of Any Histology, Except ACC (Non ACC)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 30
- upper Limit
- 88
- value
- 58
- group Id
- BG001
- lower Limit
- 57
- upper Limit
- 88
- value
- 64
- group Id
- BG002
- lower Limit
- 30
- upper Limit
- 88
- value
- 64
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 31
- title
- Female
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 33
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 30
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 59
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 4
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 54
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 5
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 32
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 64
- title
- United States
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle